Ascletis phase I COVID trial progressing
Ascletis Pharma Inc. has announced the dosing of four healthy subjects in its multiple-dose escalation…
Ascletis Pharma Inc. has announced the dosing of four healthy subjects in its multiple-dose escalation…
Ascletis Pharma Inc. has announced positive topline results from its phase I multiple ascending dose…
Ascletis Pharma Inc. has revealed that the U.S. Food and Drug Administration (FDA) has approved…
Ascletis Pharma has announced the approval of the investigational new drug (IND) application by China…
A drug to treat monkeypox from Ascletis Pharma has had its investigational new drug (IND)…
An investigational new drug (IND) application for a COVID-19 treatment has been approved by the…
A randomized, placebo-controlled study in mild to moderate COVID-19 patients has been approved by the…